RBR-54j3726招募中4 期
Clozapine for the treatment of refractory disruptive behaviors in 10-18 years old patients with Autism Spectrum Disorder: an open-label trial
Hospital de Clínicas de Porto Alegre0 个研究点开始时间: 2022年6月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 10Y 至 18Y（—）
入选标准
- •Diagnosis of Autism Spectrum Disorder; boys and girls aged 10 to 18 years; disruptive behaviors with two failures of antipsychotic treatment; Moderate or greater behavioral problems as measured by a Clinical Global Impression Scale—Severity (CGI-S) score of 4 or higher at screening; involvement of a parent or caregiver able to consistently complete assessments throughout the study.
排除标准
- •Clinical disease that contraindicates the use of clozapine; history of serious side effects to clozapine; previous treatment failure to the use of clozapine; pregnancy or breastfeeding; absence of psychosocial support considered enough to follow the study protocol.
研究者
相似试验
已完成
4 期
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineSchizophreniaNCT01401491Taipei Medical University Hospital80
终止
2 期
Clozapine and risperidone for the treatment of progressive multiple sclerosis (CRISP)progressive multiple sclerosisNeurological - Multiple sclerosisACTRN12616000178448Victoria University of Wellington36
已完成
2 期
Memantine as an adjunctive therapy to ongoing clozapine treatment: a proof-of-concept study and follow-up studyISRCTN14760638Mental Health Service Organisation North Holland North, Community Mental Health Division52
已完成
不适用
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)SchizophreniaNCT00753051Khon Kaen University18
尚未招募
Unknown
An Educational tool targeting the symptoms of constipation among people prescribed Clozapine.ConstipationACTRN12623001053617Sydney Local Health District66